Regenex MSC — Mesenchymal Stem Cell Product
Regenex MSC is our flagship regenerative cell therapy product — allogeneic mesenchymal stem cells derived from ethically sourced umbilical cord tissue, manufactured at Passage 2 in our cGMP-certified laboratory, and supplied with full batch-level quality documentation.
Full Product Specifications
| Cell Type | Mesenchymal Stem Cells (MSC) |
| Tissue Source | Human umbilical cord — Wharton's jelly |
| Donor Type | Allogeneic — pooled multi-donor |
| Donor Screening | Comprehensive infectious disease panel (HIV, HBV, HCV, syphilis, CMV, etc.) |
| Passage Level | Passage 2 |
| Identity Markers | CD73+ / CD90+ / CD105+ / CD34− / CD45− / HLA-DR− |
| Viability (release) | ≥90% live cells at release |
| Sterility | No bacterial or fungal growth at 14 days |
| Endotoxin | <0.5 EU/mL |
| Mycoplasma | Negative (PCR-based testing) |
| Storage | Cryopreserved in validated cryoprotectant medium |
| Packaging | Cryovial — single-use |
| Traceability | Blockchain-verified from donor to delivery |
| Documentation | Certificate of Analysis per batch |
Clinical Applications
Regenex MSC products are used in regenerative protocols for anti-aging and longevity, osteoarthritis and joint repair, chronic wounds and limb ischemia, hair loss, neurological support, diabetes, erectile dysfunction and general immune modulation. Clinical application is determined by the treating physician.
View MSC Therapy clinical informationWhy Passage 2 Matters
Our MSC products are manufactured exclusively at Passage 2. Later-passage cells (P4, P5+) show reduced viability, altered gene expression and diminished therapeutic consistency. Passage 2 costs more to produce but delivers the highest quality cells to every patient and clinic partner.
Learn more about our manufacturing technologyEnquire About MSC Supply
Regenex MSC products are available for clinical supply through our partnership programme.